These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19496530)

  • 1. [Melatonina: old molecule, new medicament].
    Fernández-Tresguerres Hernández JA
    An R Acad Nac Med (Madr); 2008; 125(4):681-96. PubMed ID: 19496530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does melatonin play a role in aging processes?
    Karasek M
    J Physiol Pharmacol; 2007 Dec; 58 Suppl 6():105-13. PubMed ID: 18212404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin--a possible link between sleep and the immune system.
    Haimov I; Shochat T; Lavie P
    Isr J Med Sci; 1997 Apr; 33(4):246-50. PubMed ID: 9347872
    [No Abstract]   [Full Text] [Related]  

  • 4. [Melatonin and its biological significance].
    Boguszewska A; Pasternak K
    Pol Merkur Lekarski; 2004 Nov; 17(101):523-7. PubMed ID: 15754649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin for primary insomnia?
    Drug Ther Bull; 2009 Jul; 47(7):74-7. PubMed ID: 19567841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Melatonin. Hormone or wonder drug?].
    Stoll S; Müller WE
    Med Monatsschr Pharm; 1996 Mar; 19(3):69-75. PubMed ID: 8868964
    [No Abstract]   [Full Text] [Related]  

  • 7. Relevance of the chronobiological and non-chronobiological actions of melatonin for enhancing therapeutic efficacy in neurodegenerative disorders.
    Cecon E; Markus RP
    Recent Pat Endocr Metab Immune Drug Discov; 2011 May; 5(2):91-9. PubMed ID: 22074584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orally administered melatonin improves nocturnal rest in young and old ringdoves (Streptopelia risoria).
    Paredes SD; Terrón MP; Valero V; Barriga C; Reiter RJ; Rodríguez AB
    Basic Clin Pharmacol Toxicol; 2007 Apr; 100(4):258-68. PubMed ID: 17371530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Melatonin as a drug: present status and perspectives].
    Arushanian ÉB
    Eksp Klin Farmakol; 2014; 77(6):39-44. PubMed ID: 25102735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of light regimens and melatonin on homeostasis, life span and spontaneous tumorigenesis in male rats].
    Vinogradova IA; Bukalev AV; Zabezhinskiĭ MA; Semenchenko AV; Anisimov VN
    Vopr Onkol; 2008; 54(1):70-7. PubMed ID: 18416062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin: therapeutic and clinical utilization.
    Altun A; Ugur-Altun B
    Int J Clin Pract; 2007 May; 61(5):835-45. PubMed ID: 17298593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Melatonin in the elderly and Alzheimer's disease].
    Savaskan E
    Praxis (Bern 1994); 2006 Nov; 95(47):1837-9. PubMed ID: 17168080
    [No Abstract]   [Full Text] [Related]  

  • 13. Suprachiasmatic nucleus and melatonin: reciprocal interactions and clinical correlations.
    Benarroch EE
    Neurology; 2008 Aug; 71(8):594-8. PubMed ID: 18711114
    [No Abstract]   [Full Text] [Related]  

  • 14. Possible involvement of GABAergic mechanism in protective effect of melatonin against sleep deprivation-induced behaviour modification and oxidative damage in mice.
    Kumar A; Singh A
    Fundam Clin Pharmacol; 2009 Aug; 23(4):439-48. PubMed ID: 19709322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin Can Modulate Neurodegenerative Diseases by Regulating Endoplasmic Reticulum Stress.
    Yoo YM; Joo SS
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.
    Olcese JM; Cao C; Mori T; Mamcarz MB; Maxwell A; Runfeldt MJ; Wang L; Zhang C; Lin X; Zhang G; Arendash GW
    J Pineal Res; 2009 Aug; 47(1):82-96. PubMed ID: 19538338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical implications of melatonin: receptor-mediated and receptor-independent actions.
    Reiter RJ; Tan DX; Manchester LC; Pilar Terron M; Flores LJ; Koppisepi S
    Adv Med Sci; 2007; 52():11-28. PubMed ID: 18217386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin: implications at the oral level.
    Cutando A; Silvestre FJ
    Bull Group Int Rech Sci Stomatol Odontol; 1995; 38(3-4):81-6. PubMed ID: 7492898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Controlled release melatonin (Circadin) in the treatment of insomnia in older patients: efficacy and safety in patients with history of use and non-use of hypnotic drugs].
    Zisapel N
    Harefuah; 2009 May; 148(5):337-41, 348. PubMed ID: 19630367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin and the immune system in aging.
    Cardinali DP; Esquifino AI; Srinivasan V; Pandi-Perumal SR
    Neuroimmunomodulation; 2008; 15(4-6):272-8. PubMed ID: 19047804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.